Cardiology

Managing Your Blood Pressure: The Standard of Care

At a Glance

Brachydactyly-arterial hypertension syndrome (HTNB) usually requires lifelong, individualized blood pressure treatment. Medicines often control it, while home or 24-hour monitoring helps guide targets; severe high blood pressure with warning symptoms requires emergency care.

The primary goal of managing Brachydactyly-Arterial Hypertension Syndrome (HTNB) is to achieve and maintain strict, long-term control of blood pressure ^[1]. Because this condition carries a historical risk of stroke before the age of 50 if left untreated, consistent medical management is the most important tool you have to protect your health ^[2]^[1].

Targeted Medication Strategies

While the hypertension in HTNB is primarily driven by abnormal vascular resistance rather than salt retention, it is fortunately medically responsive ^[3]^[4]. This means that while lifestyle measures like diet and exercise support overall cardiovascular health, they generally cannot replace medication for this monogenic hypertension ^[3].

There is no specific “HTNB drug” targeted precisely to PDE3A, nor is there robust evidence proving one class universally superior for this syndrome. Instead, doctors individualize treatment based on general hypertension practice and clinical experience, using several classes of well-established medications:

ACE Inhibitors and ARBs: These help relax blood vessels by blocking the hormones that cause them to constrict ^[5]. (Note: These medications are not safe during pregnancy. Women of childbearing age should receive specific safety counseling.)
Calcium-Channel Blockers (CCBs): These prevent calcium from entering the muscle cells of the heart and blood vessel walls, which allows the vessels to relax ^[5]^[6].
Thiazide Diuretics: These medications are still sometimes used as part of a combination therapy to help reach blood pressure goals ^[7]^[8].

In many cases, a single medication is not enough to control the severe hypertension seen in HTNB. Your doctor may prescribe a combination therapy—two or more drugs from different classes—to bring your pressure into a safe range ^[9]^[10]. Do not stop or change medications abruptly without medical advice.

Long-Term Monitoring and Goals

Treatment for HTNB is a lifelong commitment. The “target” for blood pressure is highly individualized. While general adult guidelines often mention a target of below 130/80 mmHg, this is not universally applicable to everyone, especially for children, pregnant individuals, older adults, or those with existing vascular disease ^[11]^[12]. For children and adolescents, targets are based on age, sex, and height percentiles ^[13].

To ensure your treatment is working, your medical team may recommend:

Home Blood Pressure Monitoring: Regularly checking your pressure at home provides a more accurate picture of your health than a single reading in a doctor’s office ^[12].
Ambulatory Blood Pressure Monitoring (ABPM): This involves wearing a small device for 24 hours that checks your pressure periodically, including while you sleep ^[13]^[14]. This is especially helpful for detecting non-dipping, where blood pressure stays high at night ^[14].

Managing Hypertensive Emergencies

A hypertensive emergency occurs when blood pressure is extremely high and is accompanied by signs of acute damage to organs like the brain, heart, or kidneys ^[15]^[16]. Symptoms can include severe headaches, vision loss, confusion, chest pain, or shortness of breath ^[15]^[17].

If you experience any of these symptoms, call emergency services immediately. Do not try to lower the pressure rapidly or adjust medication at home.

In these critical situations in the hospital, treatment is clinician-directed and individualized. The target for blood pressure reduction, and the timeline over which it happens, depends entirely on the specific emergency (for instance, treatment for an aortic dissection differs significantly from treatment for a stroke). There is no universal “fixed schedule” for all emergencies ^[18]^[19].

By working closely with a hypertension specialist and adhering to your prescribed individualized regimen, you can manage the risks of HTNB and maintain your long-term vascular health ^[1]^[3].

Common questions in this guide

What medicines are used to treat high blood pressure in HTNB?

There is no medication designed specifically for HTNB or PDE3A, so clinicians generally use established hypertension medicines. Options include ACE inhibitors or ARBs, calcium-channel blockers, and thiazide diuretics, often in combination when one medicine is not enough. ACE inhibitors and ARBs are not safe during pregnancy.

What blood pressure goal should I have with HTNB?

Your blood pressure target should be individualized with your clinician. A general adult goal below 130/80 mmHg may not apply to children, pregnant people, older adults, or people with existing vascular disease. For children and adolescents, targets are based on age, sex, and height.

How can I monitor my blood pressure outside the clinic?

Regular home readings can show your usual blood pressure more accurately than a single office measurement. A 24-hour ambulatory monitor checks pressure during the day and night and can identify non-dipping, when blood pressure remains high during sleep. Your medical team can recommend the method and schedule that fit your needs.

When does high blood pressure become an emergency in HTNB?

A hypertensive emergency is extremely high blood pressure together with signs of acute injury to the brain, heart, kidneys, or another organ. Severe headache, vision loss, confusion, chest pain, or shortness of breath are warning symptoms. Call emergency services immediately and do not try to lower the pressure rapidly or change medication at home.

Why might I need two or more blood pressure medicines?

The severe hypertension associated with HTNB may not reach a safe range with one medicine. Clinicians may combine drugs from different classes, such as a calcium-channel blocker with another blood pressure medicine, to improve control. Do not stop or change any medication without medical advice.

Can diet and exercise replace medication for HTNB?

Healthy eating and regular physical activity support cardiovascular health, but they generally cannot replace medication for HTNB. The high blood pressure is primarily related to abnormal resistance in the blood vessels, so follow the treatment plan prescribed by your clinician.

Get notified when new evidence is published on Brachydactyly-arterial hypertension syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References (19)

1
Hypertension and Brachydactyly Syndrome Associated With Vertebral Artery Malformation Caused by a PDE3A Missense Mutation.
Fan P, Zhang D, Yang KQ, et al.
American journal of hypertension 2020; (33(2)):190-197 doi:10.1093/ajh/hpz151.
PMID: 31549136
2
PDE3A mutations cause autosomal dominant hypertension with brachydactyly.
Maass PG, Aydin A, Luft FC, et al.
Nature genetics 2015; (47(6)):647-53 doi:10.1038/ng.3302.
PMID: 25961942
3
PDE3A gene screening improves diagnostics for patients with Bilginturan syndrome (hypertension and brachydactyly syndrome).
Renkema KY, Westermann JM, Nievelstein RAJ, et al.
Hypertension research : official journal of the Japanese Society of Hypertension 2018; (41(11)):981-988 doi:10.1038/s41440-018-0094-5.
PMID: 30209282
4
Mutations in Phosphodiesterase 3A (PDE3A) Cause Hypertension Without Cardiac Damage.
Ercu M, Walter S, Klussmann E
Hypertension (Dallas, Tex. : 1979) 2023; (80(6)):1171-1179 doi:10.1161/HYPERTENSIONAHA.122.19433.
PMID: 37035914
5
Arterial Hypertension.
Jordan J, Kurschat C, Reuter H
Deutsches Arzteblatt international 2018; (115(33-34)):557-568.
PMID: 30189978
6
A Multispecialty Consensus on Individualized Treatment Strategies for Hypertension Phenotypes and Comorbidities.
Wander GS, Tewary K, Muruganathan A, et al.
The Journal of the Association of Physicians of India 2025; (73(8)):77-84 doi:10.59556/japi.73.1092.
PMID: 40955890
7
First-line drugs for hypertension.
Wright JM, Musini VM, Gill R
The Cochrane database of systematic reviews 2018; (4()):CD001841 doi:10.1002/14651858.CD001841.pub3.
PMID: 29667175
8
[Management of arterial hypertension].
Groha P, Schunkert H
Herz 2015; (40(6)):929-40; quiz 941-2 doi:10.1007/s00059-015-4349-5.
PMID: 26303172
9
The use of single-pill combinations as first-line treatment for hypertension: translating guidelines into clinical practice.
Campana E, Cunha V, Glaveckaite S, et al.
Journal of hypertension 2020; (38(12)):2369-2377 doi:10.1097/HJH.0000000000002598.
PMID: 32833920
10
The Rationale for Using Fixed-Dose Combination Therapy in the Management of Hypertension in Colombia: A Narrative Review.
Molina de Salazar DI, Coca A, Alcocer L, Piskorz D
American journal of cardiovascular drugs : drugs, devices, and other interventions 2024; (24(2)):197-209 doi:10.1007/s40256-024-00634-8.
PMID: 38489104
11
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.
Ettehad D, Emdin CA, Kiran A, et al.
Lancet (London, England) 2016; (387(10022)):957-967 doi:10.1016/S0140-6736(15)01225-8.
PMID: 26724178
12
Key highlights of the Japanese Society of Hypertension Guidelines for the management of elevated blood pressure and hypertension 2025 (JSH2025).
Ohya Y, Sakima A, Arima H, et al.
Hypertension research : official journal of the Japanese Society of Hypertension 2025; (48(10)):2500-2511 doi:10.1038/s41440-025-02331-8.
PMID: 40877471
13
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents.
Flynn JT, Kaelber DC, Baker-Smith CM, et al.
Pediatrics 2017; (140(3)) doi:10.1542/peds.2017-1904.
PMID: 28827377
14
Hypertension: Evaluation and Management.
Mishra K
Indian journal of pediatrics 2026; (93(5)):522-528 doi:10.1007/s12098-026-06121-z.
PMID: 41944982
15
Hypertensive crisis in children and adolescents.
Seeman T, Hamdani G, Mitsnefes M
Pediatric nephrology (Berlin, Germany) 2019; (34(12)):2523-2537 doi:10.1007/s00467-018-4092-2.
PMID: 30276533
16
Hypertensive Crisis in Pediatric Patients: An Overview.
Raina R, Mahajan Z, Sharma A, et al.
Frontiers in pediatrics 2020; (8()):588911 doi:10.3389/fped.2020.588911.
PMID: 33194923
17
A Prospective, Observational Study to Determine the Prevalence and Clinical Profile of Patients of Hypertensive Crisis in a Tertiary Care Hospital.
Salagre SB, Itolikar SM, Gedam K
The Journal of the Association of Physicians of India 2017; (65(6)):14-21.
PMID: 28782308
18
[Hypertensive urgencies and emergencies in pediatric patients].
Skrzypczyk P, Markiewicz M, Tutka A, Pańczyk-Tomaszewska M
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 2021; (49(292)):306-310.
PMID: 34464374
19
Evaluation and treatment of hypertensive crises in children.
Stein DR, Ferguson MA
Integrated blood pressure control 2016; (9()):49-58 doi:10.2147/IBPC.S50640.
PMID: 27051314

This page is for informational purposes only and does not constitute medical advice. A hypertension specialist should individualize your HTNB medications, blood pressure targets, monitoring, and emergency plan.

Guide Contents